search
Back to results

Role of Transrectal-ultrasound in Evaluation of Azoospermia

Primary Purpose

Infertility Due to Azoospermia

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
transrectal ultrasound
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Infertility Due to Azoospermia

Eligibility Criteria

18 Years - 60 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • • Adult patients with azoospermia as identified by semen analysis.

    • Age from 18 years to more

Exclusion Criteria:

  • • History of operative intervention in the lower urinary tract.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Other

    Arm Label

    azoospermic patients

    Arm Description

    Outcomes

    Primary Outcome Measures

    Number of patients With obstructive azoospermia
    Number of patient with non obstructive azoospermia
    Number of patient that will respond to endoscopic treatment
    Number of patients that will need sperm extraction

    Secondary Outcome Measures

    Full Information

    First Posted
    August 4, 2021
    Last Updated
    August 23, 2021
    Sponsor
    Assiut University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05026190
    Brief Title
    Role of Transrectal-ultrasound in Evaluation of Azoospermia
    Official Title
    Role of Transrectal-ultrasound in Evaluation of Azoospermia
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 5, 2021 (Anticipated)
    Primary Completion Date
    December 5, 2022 (Anticipated)
    Study Completion Date
    December 5, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Assiut University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Azoospermia is a word meaning to ejaculates with no spermatozoa without a definite underlying cause .1% of men has azoospermia, representing nearly 10 to 15% of all infertile men. The azoospermia is a major concern in our community. There is no actual epidemiological studies to estimate the actual numbers in Egypt. Azoospermia has several classifications, pre-testicular, testicular & post-testicular cause .The semen analysis is the main investigation done for these patient .The treatment methods range from hormonal therapy to surgery or ICSI . The imaging modalities has developed greatly in the last 3 decades. That it became in several setting as a bedside test or investigation. The main modalities used in azoospermia are scrotal ultrasound, TRUS and MRI. The first TRUS was introduced 1957.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Infertility Due to Azoospermia

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    50 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    azoospermic patients
    Arm Type
    Other
    Intervention Type
    Diagnostic Test
    Intervention Name(s)
    transrectal ultrasound
    Intervention Description
    we perform trus to identify the cause of azospermia and its type either obstructive or not
    Primary Outcome Measure Information:
    Title
    Number of patients With obstructive azoospermia
    Time Frame
    through study completion ,within average one year.
    Title
    Number of patient with non obstructive azoospermia
    Time Frame
    through study completion , within average one year.
    Title
    Number of patient that will respond to endoscopic treatment
    Time Frame
    6 month duration
    Title
    Number of patients that will need sperm extraction
    Time Frame
    9 month duration

    10. Eligibility

    Sex
    Male
    Gender Based
    Yes
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: • Adult patients with azoospermia as identified by semen analysis. Age from 18 years to more Exclusion Criteria: • History of operative intervention in the lower urinary tract.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    mohamed m elsharkawy
    Phone
    01065811880
    Email
    mohamed.20134308@med.au.edu.eg

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    23503953
    Citation
    Aziz N. The importance of semen analysis in the context of azoospermia. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):35-8. doi: 10.6061/clinics/2013(sup01)05.
    Results Reference
    background
    PubMed Identifier
    23503952
    Citation
    Gudeloglu A, Parekattil SJ. Update in the evaluation of the azoospermic male. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):27-34. doi: 10.6061/clinics/2013(sup01)04.
    Results Reference
    background
    PubMed Identifier
    23503951
    Citation
    Cocuzza M, Alvarenga C, Pagani R. The epidemiology and etiology of azoospermia. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):15-26. doi: 10.6061/clinics/2013(sup01)03.
    Results Reference
    background
    PubMed Identifier
    29594932
    Citation
    Sihag P, Tandon A, Pal R, Jain BK, Bhatt S, Kaur S, Sinha A. Sonography in male infertility: a look beyond the obvious. J Ultrasound. 2018 Sep;21(3):265-276. doi: 10.1007/s40477-018-0294-5. Epub 2018 Mar 28.
    Results Reference
    background

    Learn more about this trial

    Role of Transrectal-ultrasound in Evaluation of Azoospermia

    We'll reach out to this number within 24 hrs